Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Post by Nohandledzepon May 03, 2013 12:05am
213 Views
Post# 21337930

Immunocidin

Immunocidin

GWB... You 'll be pleased to know that Immunocidin is now being advertised in Clinician's Brief, which is what could be called the main journal of the NA vet community.

 

Of interest, the term "cancer" is featured very prominently in the ads I was emailed. Also of interest, is that they are very openly marketing the 88% cure rate of Immunocidin and the fact that studies have indicated its effectiveness on several other forms of canine cancer... Reminded me of that idea of liberal "off label" use amongst vets.

 

The ads themselves direct you to Immunicidin.com. I am assuming that once there you would locate one of the 6 or 7 distributors in the US.

 

I am sure that it is simply a last ditch attempt at generating sales before the inevitable, but it is odd that just a few short months ago, Bioniche seemed very reluctant to use the term "cancer" in any of the news releases involving  Immunocidin. You know the ones shareholders and the market in general would have seen?

 

" Cancer treatment " and "88% cure rate" does have a certain negative connotation to it, doesn't it??? It jumped off the page when I saw it. And here I thought that Immunocidin  was used in something called canine mammory  carcinoma. That is how it was described its is NR on Thanksgiving eve launching it.

 

Certainly however, you could see why they wouldn't have interest in any unwanted attention from shareholders or potential investors. Who needs to hear about cancer, haven't we been demoralized enough?... Apparently,  all is good now though, and the terminology seems to flow quite freely in these rather obscure veterinary industry magazines.

 

Then again, if you weren't a vet, a board stiff patron in one of their waiting rooms, or abstockhouse reader at midnight, you wouldn't be aware of it would you?

 

 

<< Previous
Bullboard Posts
Next >>